The expression of CLDN6 was lower in breast cancer tissues than non–neoplastic tissues based on a GEO dataset analysis and TMA analysis, and its low expression was associated with a poor prognosis, which is in line with the study by Jia et al. [32]. This evidence concerns the gene CLDN6 and breast carcinoma.